Policy Updates Medical Policy & Clinical GuidelinesCommercialDecember 1, 2023

Medical Policy and Clinical Guideline updates

The following new Clinical Guideline was endorsed at the August 10, 2023, Medical Policy & Technology Assessment Committee (MPTAC) meeting. This, and all Anthem Blue Cross and Blue Shield’s Medical Policies and Clinical Guidelines, are available at anthem.com. Select For Providers. Under the Provider Resources heading, select Policies, Guidelines & Manuals. Select your state. Then, select View Medical Policies & Clinical UM Guidelines.

To view Medical Policies and Clinical Utilization Management Guidelines applicable to members enrolled in the Blue Cross and Blue Shield Service Benefit Plan (commonly referred to as the Federal Employee Program® FEP), visit fepblue.org > Policies & Guidelines.

Clinical Guideline update

Adopted Clinical Guideline effective March 1, 2024

The following guideline will be applied and might result in services that were previously covered but may now be found to be not medically necessary:

  • CG-MED-88 Preimplantation Embryo Biopsy and Genetic Testing

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-044284-23-SRS44098 _coding , _policy updates , _clinical guidelines , _medical policy

PUBLICATIONS: December 2023 Provider Newsletter